Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Abiomed

Founders David Lederman

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 8
Average round size
info
The average size of a deal this fund participated in
$29M
Portfolio companies 6
Rounds per year 0.20
Lead investments 3
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.25
Exits 1
Key employees Soon

Areas of investment

  • Medical Device
  • Health Care
  • Medical
  • Biotechnology
  • Hospital
Summary

In 1981 was created Abiomed, which is appeared as Corporate Investor. The fund was located in North America if to be more exact in United States. The main office of represented Corporate Investor is situated in the Danvers.

We can highlight the next thriving fund investment areas, such as Emergency Medicine, Personal Health. Among the most popular portfolio startups of the fund, we may highlight Reprieve Cardiovascular, Protembis, Magenta Medical. The fund has exact preference in a number of founders of portfolio startups. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund.

Speaking about the real fund results, this Corporate Investor is 80 percentage points more often commits exit comparing to other organizations. Comparing to the other companies, this Abiomed performs on 9 percentage points less the average number of lead investments. The fund is generally included in 2-6 deals every year. The increased amount of exits for fund were in 2019. The important activity for fund was in 2018. The usual things for fund are deals in the range of 10 - 50 millions dollars.

The typical case for the fund is to invest in rounds with 3-4 participants. Despite the Abiomed, startups are often financed by Genesis Capital, Exigent Capital, T. Rowe Price. The meaningful sponsors for the fund in investment in the same round are Pitango Venture Capital, JAFCO Japan, Genesis Capital. In the next rounds fund is usually obtained by Pitango Venture Capital, New Enterprise Associates, JVC Investment Partners.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Abiomed:
Typical Co-investors
Abiomed is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Abiomed:
There are no funds here. If we find new data, we will add it here.

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Protembis

Emergency Medicine
Health Care
Life Science
Medical Device
Personal Health
$10M13 Sep 2018 North Rhine-Westphalia

Magenta Medical

Health Care
Medical
Medical Device
$15M28 Sep 2017 North District

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Abiomed?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 8
Average round size 29M
Rounds per year 0.20
Peak activity year 2018
Lead investments 3
Follow on index 0.25
Exits 1
Group Appearance index 0.88

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Protembis

Emergency Medicine
Health Care
Life Science
Medical Device
Personal Health
$10M13 Sep 2018 North Rhine-Westphalia

Magenta Medical

Health Care
Medical
Medical Device
$15M28 Sep 2017 North District
Crunchbase icon

Content report

The following text will be sent to our editors: